Neonatal effects of breast cancer chemotherapy administered during pregnancy

Pharmacotherapy

Volumn 25, Issue 3, 2005, Pages 438-441

  Kerr, Julia R ^a  

^a St Luke's Mountain States Tumor Institute   (United States)

Author keywords

Breast cancer; Chemotherapy; Cyclophosphamide; Doxorubicin; Pregnancy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ANEMIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CASE REPORT; DRUG EFFECT; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; MALE; NEUTROPENIA; NEWBORN; PREGNANCY; PREMATURITY; PRENATAL DRUG EXPOSURE; PROPHYLAXIS; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SEPSIS; TERATOGENESIS;

ADULT; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; NEUTROPENIA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PREMATURE BIRTH;

EID: 14544271841     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.25.3.438.61590     Document Type: Article

References (22)

1. Saunders CM, Baum M. Breast cancer and pregnancy: a review. J R Soc Med 1993;86:162-5.
2. Anderson JM. Mammary cancers and pregnancy. Br Med J 1979;1:1124-7.
3. Donegan W. Breast cancer and pregnancy. Obstet Gynecol 1977;50:244-52.
4. Sorosky JI, Scott-Conner CE. Breast disease complicating pregnancy. Obstet Gynecol Clin North Am 1998;25:353-63.
5. Berry DL, Theriault RL, Holmes FA, et al. Management of breast cancer during pregnancy using a standardized protocol. J Clin Oncol 1999;17:855-61.
6. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg 1953;32(4):260-7.
7. Bardella IJ. Pediatric advanced life support: a review of the AHA recommendations: American Heart Association. Am Fam Physician 1999;60:1743-50.
8. Zubrow AB, Hulman S, Kushner H, Falkner B. Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study: Philadelphia neonatal blood pressure study group. J Perinatol 1995;15:470-9.
9. Soldin SJ. Pediatric reference ranges, 3rd ed. Washington, DC: American Association for Clinical Chemistry Press; 1999.
10. Pearson HA. Blood and blood-forming tissues In: Rudolf AM, ed. Pediatrics, 21st ed. New York: McGraw-Hill, 2003:1512-82.
11. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
12. Leslie KK. Chemotherapy and pregnancy. Clin Obstet Gynecol 2002;45:153-64.
13. Anonymous. Pregnancy categories for prescription drugs. FDA Drug Bull 1982;12(3):24-5.
14. Sokal JE, Lessman EM. Effects of cancer chemotherapy agents on the human fetus. JAMA 1960;172:1765-71.
15. Nicolson HO. Cytotoxic drugs in pregnancy: review of reported cases. J Obstet Gynaecol 1968;75:307-12.
16. Bristol-Myers Squibb. Cytoxan (cyclophosphamide) product information. Princeton, NJ; 2000.
17. Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994;16:75-112.
18. Ben Venue Laboratories. Adriamycin (doxorubicin) product information. Bedford, OH; 2001.
19. Murray CL, Reichert JA, Anderson J, et al. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy: a case report. JAMA 1984;252:2607-8.
20. Germann N, Goffinet F, Goldwasser F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004;15:146-50.
21. Meyer-Wittkopf M, Earth H, Emons G, Schmidt S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 2001;18:62-6.
22. Aviles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children. Am J Hematol 1991;36:243-8.